Donald Williams - Aug 20, 2024 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role: Director
Signature: /s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Stock symbol: FBRX
Transactions as of: Aug 20, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/22/2024, 04:07 PM
Previous filing: Jul 15, 2024
Next filing: Nov 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FBRX	Stock Option (right to buy)	Award	$0	+50K		$0.00	50K	Aug 20, 2024	Common Stock	50K	$0.34	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean August 20, 2024.

Content

Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean August 20, 2024.